期刊文献+

慢性阻塞性肺病患者外周血中CD34^+细胞数量变化 被引量:9

Change of EPCs in perpherail blood of COPD patients
下载PDF
导出
摘要 目的:观察中、重度慢性阻塞性肺病(COPD)患者外周血中CD34+细胞数量变化。方法:按入选标准收集25例中、重度COPD患者外周血,应用密度梯度离心法分离单个核细胞,采用CD34+正分选试剂盒进行磁珠纯化,用流式细胞分析仪分析其纯度,同时对入选患者行常规心电图、肺功能、心动超声及血气检查。同期16例性别、年龄无差异志愿者作为对照组,入选标准:年龄<70岁;肺功能正常;没有临床症状;无吸烟史。结果:经过分离纯化可得到93%表达CD34+细胞。COPD患者组与对照组外周血中的CD34+细胞数分别是(19.99±11.11)×104、(32.75±18.25)×104,患者组CD34+细胞数明显少于对照组(P<0.05),CD34+细胞数与患者病程呈负相关(r=-0.689,P<0.05)。结论 :COPD患者外周血中CD34+细胞数降低,与患者病程呈负相关。 Objective. To observe the change of EPCs in perpherail blood of chronic obstructive pulmonary disease (COPD) patients. Methods. Based on the selection standard, peripheral blood was col- lected from media and severe COPD patients. Peripheral blood mononuclear cells (PBMCs) were obtained by standard Ficoll gradient centrifugation, and purified by CD34^+ positive selection cocktail. All subjects received a complete clinical assessment including pulmonary function tests, a 12-lead ECG and blood gas analysis. The selection standard of control group was as follows, age〈70 years old, normal pulmonary function, no clinical symptoms or smoking history. Results: 93% CD34^+ cells was obtained after isolation and purification. The count of CD34^+ cells was (19.99±11.11) ×10^4 and (32.75±18.25)×10^4in patients group and control group, respectively. The count of patients group was significantly lower (P〈0.05). There were negative correlation between CD34^+ cell counts and course of COPD(r=-0. 689 ,P〈0.05). Conclusions: The count of CD34^+ is decreased, and is negatively correlated with course of COPD.
出处 《海南医学院学报》 CAS 2014年第3期313-316,共4页 Journal of Hainan Medical University
基金 国家自然科学基金资助项目(81260010) 海南省自然科学基金资助项目(309064)~~
关键词 慢性阻塞性肺病(COPD) 心血管疾病 内皮祖细胞 COPD Cardiovascular disease Endothelial progenitor cells
  • 相关文献

参考文献10

  • 1Huertas A,Testa U,Riccioni R. Bone marrowderived progenitors are greatly reduced in patients with severe COPD and low BMI[J].{H}Respiratory Physiology & Neurobiology,2010,(1):23-31.
  • 2Palange P,Testa U,Huertas A. Circulating haemopoietic and endothelial progenitor cells are decreased inCOPD[J].{H}European Respiratory Journal,2006,(3):529-541.
  • 3Garamori G,Rigolin GM,Mazzoni F. Circulating endothelial stena cells are not decreased in pulmonary emphysema or COPD[J].{H}THORAX,2010.554-555.
  • 4Hill JM,Zalos G,Halcox JP. Circulating endothelial progenitor cells,vascular function,and cardiovascular risk[J].{H}New England Journal of Medicine,2003,(7):593-600.
  • 5Schmidt-lucke C,Rossig L,Fichtlscherer S. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events:proof of concept for the clinical importance of endogenous vascular repair[J].{H}CIRCULATION,2005,(22):29812987.
  • 6Spiegel A,Shivtiel S,Kalinkovich A. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling[J].{H}Nature Immunology,2007,(10):1123-1131.
  • 7Timmermans F,Van Hauwermeiren F,De Smedt M. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors[J].Arterioscler Thromh Vasc Biol,2007,(7):1572-1579.
  • 8Crosby JR,Kaminski WE,Schatteman G. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation[J].{H}CIRCULATION RESEARCH,2000,(9):728-730.
  • 9Asahara T,Masuda H,Takahashi T. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathologicalneovascularization[J].{H}CIRCULATION RESEARCH,1999,(3):221-228.
  • 10Kalka C,Masuda H,Takahashi T. Transplanta tion of er vivo expanded endothelial progenitor cells for therapeutic neovascularization[J].{H}Proceedings of the National Academy of Sciences(USA),2000,(7):3422-3427.

同被引文献107

  • 1李现东,韩纪昌,李磊,贾宗岭,李红兵,吴雪雁.肿瘤坏死因子-α和可溶性肿瘤坏死因子受体在慢性阻塞性肺病患者肺功能变化中的表达及意义[J].中国老年学杂志,2014,34(2):357-358. 被引量:19
  • 2王红.慢性阻塞性肺疾病合并肺间质纤维化肺部特征及肺功能的关系[J].中国误诊学杂志,2004,4(1):93-94. 被引量:11
  • 3Young J,Donahue M,Farquhar M,et al.Attitudes to Using Opioids to Treat Dyspnea in Advanced COPD:A Qualitative Study of Family Physicians and Respiratory Therapists[J].Can Fam Physician,2012,58(7):e401.
  • 4Heart Protection Study Collaborative Group,Jonathan Emberson,Derrick Bennett,et al.C-reactive protein concentration and the vascular benefits of statin therapy:an analysis of 20,536 patients in the Heart Protection Study[J].Lancet,2011,377(9764):469.
  • 5Knobloch J,Wahl C,Feldmann M,et al.Resveratrol attenu- ates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic Acid in chronic obstructive pulmonary disease[J].Basic Clin Phar- macol Toxicol,2014,114(2):202.
  • 6Ilvan A,Aslan G,Serin M S,et al.Investigation of the presence of human metapneumovirus in patients with chronic obstructive pulmonary disease and asthma and its relationship with the atiacks[J].Mikrobiyol Bui,2013,47(4):636.
  • 7Maclay JD,Mac Nee W.Cardiovascular disease in COPD:mechanisms[J].Chest,2013,143(3):798-807.
  • 8Kelly E,Owen CA,Pinto-Plata V,et al.The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease[J].Expert Rev Respir Med,2013,7(1):57-64.
  • 9Mac-Nee W.Systemic inflammatory biomarkers and comorbidities of chronic obstructive pulmonary disease[J].Ann Med,2013,45(3):291-300.
  • 10Pinto-Plata V,Casanova C,Müllerova H,et al.Inflammatory and repair serum biomarker pattern:association to clinical outcomes in COPD[J].Respir Res,2012,13:71.

引证文献9

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部